TickerGuard
Buy Day today: Neutral (48) Mixed market breadth · no major macro event
IFRX

InflaRx N.V.

Healthcare · Biotechnology

1.80$ -3.7% vs. previous close Closing price · As of: Sep 28, 2026

Statements

Income Statement

All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.

Tick rows to compare them in a chart (up to 4)

Income Statement IFRX
Line item 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
– – – -100.0% – – – – – +162.8% -82.3%
– -12.7% +87.0% +169.3% +313.3% +9.5% -2.6% -20.8% -15.1% +523.2% +119.1%
– – – – – – – – – – –
– +51.8% +173.1% +73.6% +78.1% -42.4% +39.0% +5.1% +9.3% -13.8% -27.3%
– +321.0% +178.6% +148.9% -2.2% -36.7% +44.5% +25.5% -0.9% +7.5% +1.5%
– +82.1% +172.6% +99.8% +51.3% -40.2% +40.3% -32.3% +36.9% +12.8% -17.6%
– – – – – – – – – – –
– +73.9% +21.4% -100.0% – +17.1% -4.7% +82.7% -21.3% -42.0% +82.5%
– – – – – – – – – – –
– +54.3% +21.4% +245.5% -145.6% – -4.7% -9,960.7% – – +135.4%
– – – – – – – – – – –
– – – – – – – – – – –

Data as of: September 28, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?